Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ADI 2016 | Potential new symptomatic drugs for Alzheimer’s disease

At the 31st International Conference of Alzheimer’s Disease International (ADI), held in Budapest, Hungary, from April 21–24 2016, Serge Gauthier, C.M., MD, FRCPC, from McGill Centre for Studies in Aging, McGill University, Montreal, Canada, reviews promising agents in clinical development for the symptomatic treatment of people with Alzheimer’s disease.